Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A novel, evolutionarily conserved gene family with putative sequence-specific single-stranded DNA-binding activity.

Patricia Castro1, Hong Liang, Jan C Liang

  • 1Department of Molecular Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, 77030, USA.

Genomics
|June 25, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxoaporphine Metal Complexes (Co<sup>II</sup>, Ni<sup>II</sup>, Zn<sup>II</sup>) with High Antitumor Activity by Inducing Mitochondria-Mediated Apoptosis and S-phase Arrest in HepG2.

Scientific reports·2017
Same author

Analysis of inequality in maternal and child health outcomes and mortality from 2000 to 2013 in China.

International journal for equity in health·2017
Same author

A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines.

Scientific reports·2017
Same author

A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study.

Investigative ophthalmology & visual science·2017
Same author

Prenatal exposure to β2-adrenoreceptor agonists and the risk of autism spectrum disorders in offspring.

Pharmacoepidemiology and drug safety·2017
Same author

Chemical constituents from the whole plants of Pilea cavaleriei Levl subsp. cavaleriei.

Fitoterapia·2017

Researchers identified a novel gene, SSBP2, disrupted in aggressive myeloid malignancies linked to chromosome 5q deletions. This gene and its family members may act as tumor suppressors, offering new therapeutic targets.

Area of Science:

  • Genetics
  • Molecular Biology
  • Oncology

Background:

  • Chromosome 5q deletions are common in aggressive myeloid malignancies.
  • A specific 1.5-Mb region (5q13.3) is frequently lost in leukemic cells.
  • A leukemic cell line (ML3) exhibits a translocation within this critical region.

Purpose of the Study:

  • To define the breakpoint in the 5q13.3 region associated with myeloid malignancies.
  • To identify novel genes disrupted by these chromosomal anomalies.
  • To investigate the potential tumor suppressor role of the identified gene, SSBP2.

Main Methods:

  • Construction of a bacterial artificial chromosome (BAC) contig to map breakpoints.
  • Identification and characterization of the SSBP2 gene.

Related Experiment Videos

  • Analysis of SSBP2 mutations in primary leukemic samples and cell lines.
  • Chromosomal localization of SSBP2, SSBP3, and SSBP4 genes.

    • Main Results:

    • A novel gene, SSBP2, was identified as the target of disruption in ML3 cells.
    • Preliminary data suggest SSBP2 functions as a tumor suppressor, with no intragenic mutations found in the remaining allele.
    • SSBP2 belongs to a conserved gene family, including SSBP3 (CSDP) and SSBP4, located on chromosomes 1p31.3 and 19p13.1, respectively.

    Conclusions:

    • SSBP2 is a novel gene implicated in myeloid malignancies due to chromosome 5q deletions.
    • The SSBP gene family, including SSBP2, SSBP3, and SSBP4, may possess tumor suppressor functions.
    • Further research into these genes could reveal new therapeutic strategies for myeloid cancers.